Annual Working Capital
$3.99 M
-$1.17 M-22.66%
31 December 2023
Summary:
Lixte Biotechnology Holdings annual working capital is currently $3.99 million, with the most recent change of -$1.17 million (-22.66%) on 31 December 2023. During the last 3 years, it has fallen by -$1.02 million (-20.30%). LIXT annual working capital is now -22.66% below its all-time high of $5.17 million, reached on 31 December 2022.LIXT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$1.36 M
-$886.10 K-39.45%
30 September 2024
Summary:
Lixte Biotechnology Holdings quarterly working capital is currently $1.36 million, with the most recent change of -$886.10 thousand (-39.45%) on 30 September 2024. Over the past year, it has dropped by -$3.56 million (-72.37%). LIXT quarterly working capital is now -82.22% below its all-time high of $7.65 million, reached on 31 March 2021.LIXT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIXT Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.7% | -72.4% |
3 y3 years | -20.3% | -77.5% |
5 y5 years | -3.1% | -50.7% |
LIXT Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -22.7% | at low | -81.8% | at low |
5 y | 5 years | -22.7% | +64.1% | -82.2% | +40.7% |
alltime | all time | -22.7% | +1334.1% | -82.2% | +520.1% |
Lixte Biotechnology Holdings Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.36 M(-39.5%) |
June 2024 | - | $2.25 M(-28.2%) |
Mar 2024 | - | $3.13 M(-21.7%) |
Dec 2023 | $3.99 M(-22.7%) | $3.99 M(-18.9%) |
Sept 2023 | - | $4.92 M(+82.8%) |
June 2023 | - | $2.69 M(-34.0%) |
Mar 2023 | - | $4.08 M(-21.0%) |
Dec 2022 | $5.17 M(+7.8%) | $5.17 M(-19.4%) |
Sept 2022 | - | $6.41 M(-14.4%) |
June 2022 | - | $7.49 M(+116.4%) |
Mar 2022 | - | $3.46 M(-27.7%) |
Dec 2021 | $4.79 M(-4.4%) | $4.79 M(-20.8%) |
Sept 2021 | - | $6.05 M(-11.9%) |
June 2021 | - | $6.87 M(-10.2%) |
Mar 2021 | - | $7.65 M(+52.6%) |
Dec 2020 | $5.01 M(+105.9%) | $5.01 M(+418.5%) |
Sept 2020 | - | $966.60 K(-39.2%) |
June 2020 | - | $1.59 M(-22.4%) |
Mar 2020 | - | $2.05 M(-15.7%) |
Dec 2019 | $2.43 M(-41.0%) | $2.43 M(-11.7%) |
Sept 2019 | - | $2.76 M(-18.8%) |
June 2019 | - | $3.40 M(-8.5%) |
Mar 2019 | - | $3.71 M(-10.0%) |
Dec 2018 | $4.12 M(+314.4%) | $4.12 M(<-9900.0%) |
Sept 2018 | - | -$18.70 K(-107.9%) |
June 2018 | - | $237.60 K(-61.4%) |
Mar 2018 | - | $615.90 K(-38.1%) |
Dec 2017 | $995.10 K(+363.5%) | $995.10 K(-28.7%) |
Sept 2017 | - | $1.39 M(-23.5%) |
June 2017 | - | $1.82 M(+173.7%) |
Mar 2017 | - | $666.10 K(+210.2%) |
Dec 2016 | $214.70 K(-31.3%) | $214.70 K(-70.9%) |
Sept 2016 | - | $738.00 K(-40.4%) |
June 2016 | - | $1.24 M(+20.1%) |
Mar 2016 | - | $1.03 M(+230.5%) |
Dec 2015 | $312.30 K | $312.30 K(-61.2%) |
Sept 2015 | - | $804.90 K(-39.3%) |
June 2015 | - | $1.33 M(-7.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | $1.43 M(+437.0%) |
Dec 2014 | $265.90 K(+12.6%) | $265.90 K(-55.2%) |
Sept 2014 | - | $593.90 K(-39.1%) |
June 2014 | - | $975.00 K(-1112.5%) |
Mar 2014 | - | -$96.30 K(-140.8%) |
Dec 2013 | $236.20 K(-84.2%) | $236.20 K(-59.3%) |
Sept 2013 | - | $580.30 K(-34.0%) |
June 2013 | - | $878.70 K(-27.4%) |
Mar 2013 | - | $1.21 M(-18.8%) |
Dec 2012 | $1.49 M(+1786.0%) | $1.49 M(-13.0%) |
Sept 2012 | - | $1.72 M(-9.9%) |
June 2012 | - | $1.90 M(-816.9%) |
Mar 2012 | - | -$265.50 K(-435.7%) |
Dec 2011 | $79.10 K(-95.4%) | $79.10 K(-87.6%) |
Sept 2011 | - | $638.10 K(-41.1%) |
June 2011 | - | $1.08 M(-21.8%) |
Mar 2011 | - | $1.39 M(-20.2%) |
Dec 2010 | $1.74 M(+33.5%) | $1.74 M(+0.9%) |
Sept 2010 | - | $1.72 M(-6.5%) |
June 2010 | - | $1.84 M(-13.6%) |
Mar 2010 | - | $2.13 M(+63.8%) |
Dec 2009 | $1.30 M(-501.9%) | $1.30 M(-567.0%) |
Sept 2009 | - | -$278.60 K(+266.6%) |
June 2009 | - | -$76.00 K(-47.0%) |
Mar 2009 | - | -$143.50 K(-55.7%) |
Dec 2008 | -$323.70 K(-186.0%) | -$323.70 K(+92.1%) |
Sept 2008 | - | -$168.50 K(-1618.0%) |
June 2008 | - | $11.10 K(-92.5%) |
Mar 2008 | - | $147.20 K(-60.9%) |
Dec 2007 | $376.20 K(-39.9%) | $376.20 K(+1201.7%) |
Sept 2007 | - | $28.90 K(-83.1%) |
June 2007 | - | $171.40 K(-49.3%) |
Mar 2007 | - | $338.20 K(-45.9%) |
Dec 2006 | $625.50 K(-4084.1%) | $625.50 K(-15.6%) |
Sept 2006 | - | $741.40 K(+1071.2%) |
June 2006 | - | $63.30 K(-739.4%) |
Mar 2006 | - | -$9900.00 |
Dec 2005 | -$15.70 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual working capital?
- What is the all time high annual working capital for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual working capital year-on-year change?
- What is Lixte Biotechnology Holdings quarterly working capital?
- What is the all time high quarterly working capital for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly working capital year-on-year change?
What is Lixte Biotechnology Holdings annual working capital?
The current annual working capital of LIXT is $3.99 M
What is the all time high annual working capital for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual working capital is $5.17 M
What is Lixte Biotechnology Holdings annual working capital year-on-year change?
Over the past year, LIXT annual working capital has changed by -$1.17 M (-22.66%)
What is Lixte Biotechnology Holdings quarterly working capital?
The current quarterly working capital of LIXT is $1.36 M
What is the all time high quarterly working capital for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly working capital is $7.65 M
What is Lixte Biotechnology Holdings quarterly working capital year-on-year change?
Over the past year, LIXT quarterly working capital has changed by -$3.56 M (-72.37%)